8P9X
Vitamin D receptor complex with Xe4Me agonist ligand
8P9X の概要
| エントリーDOI | 10.2210/pdb8p9x/pdb |
| 分子名称 | Vitamin D3 receptor A, Nuclear receptor coactivator 2, ACETATE ION, ... (5 entities in total) |
| 機能のキーワード | nuclear receptor, agonist, ligand binding domain, transcription |
| 由来する生物種 | Danio rerio (zebrafish) 詳細 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 36108.15 |
| 構造登録者 | |
| 主引用文献 | Len-Tayon, K.,Beraud, C.,Fauveau, C.,Belorusova, A.Y.,Chebaro, Y.,Mourino, A.,Massfelder, T.,Chauchereau, A.,Metzger, D.,Rochel, N.,Laverny, G. A vitamin D-based strategy overcomes chemoresistance in prostate cancer. Br.J.Pharmacol., 181:4279-4293, 2024 Cited by PubMed Abstract: Castration-resistant prostate cancer (CRPC) is a common male malignancy that requires new therapeutic strategies due to acquired resistance to its first-line treatment, docetaxel. The benefits of vitamin D on prostate cancer (PCa) progression have been previously reported. This study aimed to investigate the effects of vitamin D on chemoresistance in CRPC. PubMed: 38982588DOI: 10.1111/bph.16492 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.15 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






